High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during 131I-meta-iodobenzylguanidine treatment in children with neuroblastomaHanneke M. van Santen; Jan de Kraker; Berthe L. F. van Eck; Jan J. M. de Vijlder; Thomas Vulsma · 2002

Adaptive Dosing Approaches to the Individualization of 13-Cis-Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk NeuroblastomaVeal, G. J.; Errington, J.; Rowbotham, S. E.; Illingworth, N. A.; Malik, G.; Cole, M.; Daly, A. K.; Pearson, A. D. J.; Boddy, A. V. · Clinical Cancer Research · 2013

A CASE SERIES OF CHILDREN WITH HIGH-RISK METASTATIC NEUROBLASTOMA TREATED WITH A NOVEL TREATMENT STRATEGY CONSISTING OF POSTPONED PRIMARY SURGERY UNTIL THE END OF SYSTEMIC CHEMOTHERAPY INCLUDING HIGH-DOSE CHEMOTHERAPYHashii, Yoshiko; Kusafuka, Takeshi; Ohta, Hideaki; Yoneda, Akihiro; Osugi, Yuko; Kobayashi, Yasutsugu; Fukuzawa, Masahiro; Hara, Junichi · Pediatric Hematology-Oncology · 2008

Experiences from Introducing Standardized High Dose 131I-mIBG Treatment of Children with Refractory Neuroblastoma: Differences in Effective Dose to Patients and Exposure to CaregiversHjornevik, Trine; Martinsen, Anne Catrine; Hagve, Signe Elise · Journal of Nuclear Medicine & Radiation Therapy · 2015

Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into killer immunoglobulin-like receptor/HLA-ligand mismatched haploidentical stem cell transplantation for children with neuroblastoma who failed tandem autologous stem cell transplantatioLee, Ji Won; Kang, Eun-Suk; Sung, Ki Woong; Yi, Eunsang; Lee, Soo Hyun; Yoo, Keon Hee; Koo, Hong Hoe · Pediatric Blood & Cancer · 2016